BioSpace News Archive

Jeffrey Koplan , MD, MPH, vice president for Global Health at Emory University , and Amelie Ramirez , DrPH, MPH, professor and chair of the Department of Population Health Sciences and director of the Institute for Health Promotion Research at UT Health San Antonio, have each been elected to a five-year term on the board of directors of t

The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive metastatic breast cancer and previously untreated HER2-positive metastatic gastric cancer

Aquarius Surgical Technologies Inc. (CSE:ASTI) (“the Company”), announces that there will be a delay in the filing of its annual financial statements and accompanying management’s discussion and analysis, and related CEO and CFO certifications for the financial year ended March 31, 2020 (collectively “Annual Filings”) due to COVID-19 related delays.

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2020 financial results after the close of market on Wednesday, August 5, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress.

Regenerative medicine (RM) has the potential to transform healthcare by developing curative therapies for diseases such as heart failure or vision loss

A recent feasibility study conducted in collaboration between LEO Innovation Lab, VisualDx, and the German Association of Dermatological Prevention found, for the first time, a 34% increase in diagnostic accuracy by general practitioners (GPs) who use technology to assist in patient diagnosis in skin conditions, while at the same time improving patient satisfaction.

Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today the company will be participating in the upcoming virtual Canaccord 40th Annual Growth Conference.

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today that the company is presenting at several virtual investor conferences during August 2020.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced revenue of $218.4 million for the quarter ended June 30, 2020, a decrease of (14.5)% compared to revenue of $255.5 million for the quarter ended June 30, 2019.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2020 on Monday, August 10 at 4:30 p.m. ET / 1:30 p.m. PT.